Trial intelligence / Profile preview

Pioglitazone in Adolescents with Severe Sepsis

NCT01352182Phase 2Completed

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Oct 2011
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pioglitazone in sepsis, septic shock, sponsored by Cincinnati Children's Hospital Medical Center. Started Oct 2011; status: completed.

02

Drugs

pioglitazone
03

Conditions

sepsisseptic shock

Beyond the preview

Go deeper on NCT01352182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01352182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call